In blow to an­ti-ag­ing field, Uni­ty Biotech­nol­o­gy fails first ma­jor study, cuts lead pro­gram

In the last decade, Uni­ty Biotech­nol­o­gy $UBX raised over $200 mil­lion from in­vestors who saw both the com­mer­cial and per­son­al ben­e­fits in life-ex­tend­ing tech­nol­o­gy: Jeff …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER